Compare CVS Health Corp (CVS) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Tyson Foods, Inc. — how do they compare? CVS Health Corp trades at $86.2 (market cap $112.49B), while Tyson Foods, Inc. trades at $52.47 (market cap $18.19B). The key difference: CVS Health Corp is far larger — about 6.2× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays the higher dividend (3.95%). Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Tyson Foods, Inc. for 76 Days on average.
| CVS | TSN | |
|---|---|---|
Market Cap | $112.49B | $18.19B |
Volume | 8,467,392 | 3,320,883 |
Sector | Health | Consumer Staples |
52-Week High | $110.60 | $68.75 |
52-Week Low | $70.08 | $50.47 |
Typical Hold Time | 83 Days | 76 Days |
Enterprise Value | $174.83B | $25.45B |
Dividend Yield | 3.02% | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
Tyson Foods (TSN) trades at $52.34, up 0.71% with mixed technical signals showing neutral momentum. The company reported Q2 2026 EPS of $0.99 beating expectations, but faces margin pressure with net income margin at 1.03%. Recent news highlights dividend stability despite beef segment losses and ongoing securities investigations. Cash flow trends show operational strength with $2.16B from operations in 2025, though net cash flow remains negative.
The stock presents a value opportunity with P/S of 0.33 below industry averages, supported by 53% analyst buy ratings and $65.40 consensus target. However, margin compression, beef segment challenges, and legal investigations create near-term headwinds. Long-term prospects depend on operational improvements and successful navigation of current business challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
